Author

S. Yoder

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metagenomics· 1

Frequent Co-Authors

A. B. Ward· 1 shared A. Gopalan· 1 shared A. J. Rodriguez· 1 shared A. Lubbe· 1 shared A. M. Jackson· 1 shared A. Milshteyn· 1 shared A. N. Leon· 1 shared A. Torrents de la Pena· 1 shared

Activity by Year

2022-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. B. Ward

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Structural Mapping of Polyclonal IgG Responses to HA After Influenza Virus Vaccination or Infection

A. N. Leon, A. J. Rodriguez, S. T. Richey, A. Torrents de la Pena, R. M. Wolters, A. M. Jackson, K. Webb, C. B. Creech, S. Yoder, P. A. Mudd, J. E. Crowe, J. Han, A. B. Ward

The paper uses nsEMPEM to analyze polyclonal IgG responses to HA in vaccinated and infected individuals, showing differences in epitope targeting between H1 and H3 subtypes.

bioRxiv · Jul 8, 2024Immunology

The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1

R. Romero, T. Chu, T. J. Gonzalez-Robles, P. Smith, Y. Xie, H. Kaur, S. Yoder, H. Zhao, C. Mao, W. Kang, M. Pulina, K. E. Lawrence, A. Gopalan, S. Zaidi, K. Yoo, , C. Sawyers

This study identifies ASCL1 as a critical driver of neuroendocrine lineage transition in prostate cancer using an in vivo model and spatial transcriptomics.

bioRxiv · Apr 9, 2024Cancer Biology

Precision Discovery of Novel Inhibitors of Human Cancer Target HsMetAP1 from Vast Unexplored Metagenomic Diversity

O. W. Liu, S. Akers, G. Alvarez, S. Brown, W. Cai, Z. Charlop-Powers, K. Crispell, E.-B. Goh, W. W. Hwang, T. H. Eyles, S. Ganesh, P. Haverty, J. L. Kulp, J. L. Kulp, Z. Kurtz, , D. R. Scannell

The paper discovers novel inhibitors of HsMetAP1 from metagenomic data using computational and synthetic biology methods.

bioRxiv · Jun 11, 2022 · PreprintMicrobiology